Global software developer Eschbach, provider of Shiftconnector digital manufacturing software for the pharmaceutical, chemical and food manufacturing sectors, announces a partnership to integrate Shiftconnector and Cleared4, an employee health monitoring platform. The integration will support healthy, safe and reliable production at manufacturing plants, according to the company.
Shiftconnector, in combination with Cleared4, reportedly becomes the first shift-to-shift handover software in the industry to directly address the multitude of health and safety issues brought on by the COVID-19 pandemic. The offering simultaneously solves digital communications and collaboration challenges during shift-to-shift handovers, including reporting and contract tracing, management of process upsets and compliance-related routine activities.
“Shiftconnector has become increasingly important during the pandemic with manufacturing teams working both remotely and with skeleton teams onsite,” says Andreas Eschbach, CEO of Eschbach. “The opportunity to integrate Cleared4 provides another level of safety for manufacturing operations and helps to mitigate risks and liabilities faced by the organization, especially in highly regulated industries like pharma and chemical. This partnership will help to ensure that operations have healthy staff to facilitate production.”
The integration of Cleared4 with Shiftconnector provides a health management dashboard, including text messaging, health-centric technologies and on-site kiosks to obtain valuable health clearance and optimize safety as employees enter their facility to start their shift. Additionally, the platform gives access to COVID-19 test results for staff and integrates influenza and COVID-19 vaccination status, allowing employers to track their employee health and contacts.
“We are delighted about this partnership and with our seamless integration with Eschbach to help extend our Cleared4 platform deeper into the critical manufacturing space. Our platform can improve an organization’s compliance with COVID-19 protocols and ensure they are future-proofed for up-and-coming regulations around contact tracing and vaccination tracking,” says Dr. Soumi Eachempati, founder and CEO of Chelsea Health Solutions and innovator of Cleared4.
For more information, visit: www.eschbach.com
